Blue Owl Capital Corporation Common Stock OBDC 深 沪
已收盘 09-05 16:00:00 美东时间
14.34
-0.020
-0.14%
华盛通- 最 高14.4399
- 今 开14.40
- 成交量 199.66万股
- 最 低 14.25
- 昨 收 14.36
- 总市值 73.28亿
- 52周最高 15.165
- 市盈率 静 9.40
- 换手率 0.00%
- 52周最低 11.71
- 委 比 -50.94%
- 总股本 5.11亿
- 历史最高 14.91
- 量 比 0.80
- 振 幅 1.32%
- 历史最低 -0.13
- 每 手 1
- 风险率 0.98%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Clear Street Initiates Coverage On Blue Owl Capital with Buy Rating, Announces Price Target of $15
Clear Street analyst Mickey Schleien initiates coverage on Blue Owl Capital (NYSE:OBDC) with a Buy rating and announces Price Target of $15.
09-05 17:32
美股9月收息策略：最高股息率超15%！默沙东、惠普、必和必拓等180多家高分红股如何布局？
最高股息率超15%！默沙东、惠普、必和必拓等180多家美股公司即将派息；投资者若想赚取股息，可趁未除净适时部署，一文速览派息名单>>
09-01 19:16
Wealthy individuals fuel boom in private credit: FT
Private credit funds are attracting record inflows from wealthy investors, making up for slower commitments from pensions and endowments, the Financial Times reported on Sunday. Affluent Americans i...
08-31 21:00
Blue Owl Capital Updates Secured Credit Facility
Blue Owl Capital ( ($OBDC) ) just unveiled an announcement. On August 15, 2025,...
08-19 05:00
3 Income Stocks The Best In The Business Are Buying Now
The story of Ares Management Corporation (NYSE:ARES) begins in the rubble of on...
08-16 03:16
Blue Owl Capital declares $0.37 dividend
Blue Owl Capital (NYSE:OBDC) declares $0.37/share quarterly dividend, in line with previous. Payable Oct. 15; for shareholders of record Sept. 30; ex-div Sept. 30. The Board also declared a second qu...
08-07 04:58
Earnings Scheduled For August 6, 2025
Companies Reporting Before The Bell • Lineage (NASDAQ:LINE) is likely to report...
08-06 16:33
美股6月收息策略：最高股息率超9%！默沙东、惠普、百事可乐等近90家高分红股如何布局？
最高股息率超13%！默沙东、惠普、百事可乐等近90家美股即将派息；投资者若想赚取股息，可趁未除净适时部署，一文速览派息名单>>
05-31 10:07
美股大行评级 | 潜在涨幅2840.31%！Mersana Therapeutics获Truist Securities升目标价至10美元，维持"买入"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1130419824951111681.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Truist Securities：维持Mersana Therapeutics(MRSN)"买入"评级，目标价从9美元升至10美元</p> <p>• Guggenheim：维持Cabaletta Bio(CABA)"买入
05-17 08:44
美股大行评级 | 潜在涨幅1281.22%！Cabaletta Bio获Guggenheim升目标价至25美元，维持"买入"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1130057143861719040.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Guggenheim：维持Cabaletta Bio(CABA)"买入"评级，目标价从23美元升至25美元</p> <p>• 瑞穗：维持Tectonic Therapeutic(TECX)"跑赢大市"评级，目标价从51美元
05-16 08:43
